These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24916368)

  • 61. Preventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II).
    Jacobsen PK
    J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):55-68. PubMed ID: 16470484
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: how much is too much?
    Pitt B
    Curr Heart Fail Rep; 2009 Jun; 6(2):112-6. PubMed ID: 19486595
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin-angiotensin system inhibitors.
    Terano C; Ishikura K; Miura M; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Ando T; Honda M
    Eur J Pediatr; 2016 May; 175(5):631-7. PubMed ID: 26687571
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Renin inhibition--benefit beyond hypertension control.
    Kher V
    J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Direct renin inhibitors: ONTARGET for success?
    Pasha Y; Gusbeth-Tatomir P; Covic A; Goldsmith D
    Int Urol Nephrol; 2009; 41(2):341-55. PubMed ID: 19296235
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dual renin-angiotensin system blockade: on the target.
    Robles NR
    Int J Clin Pract; 2008 Aug; 62(8):1134-6. PubMed ID: 18705817
    [No Abstract]   [Full Text] [Related]  

  • 67. Renal effects of dual renin-angiotensin-aldosterone system blockade in patients with diabetic nephropathy.
    Dalla Vestra M; Simioni N; Masiero A
    Int Urol Nephrol; 2009; 41(1):119-26. PubMed ID: 18958580
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hyperkalemia risk and treatment of heart failure.
    Segura J; Ruilope LM
    Heart Fail Clin; 2008 Oct; 4(4):455-64. PubMed ID: 18760757
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
    Verdecchia P; Gentile G; Angeli F; Reboldi G
    Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of renin-angiotensin system inhibitors in atrial fibrillation.
    Disertori M; Latini R; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):374; author reply 375. PubMed ID: 21451337
    [No Abstract]   [Full Text] [Related]  

  • 72. Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis.
    Chrysant SG; Murray AV; Hoppe UC; Dattani D; Patel S; Hsu H; Zhang J
    Curr Med Res Opin; 2008 Apr; 24(4):1039-47. PubMed ID: 18307835
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Atrial fibrillation: Blockade of the renin-angiotensin system in atrial fibrillation.
    Kuzniatsova N; Shantsila E; Lip GY
    Nat Rev Cardiol; 2010 Aug; 7(8):428-30. PubMed ID: 20657612
    [No Abstract]   [Full Text] [Related]  

  • 74. Left ventricular hypertrophy and renin-angiotensin system blockade.
    Cowan BR; Young AA
    Curr Hypertens Rep; 2009 Jun; 11(3):167-72. PubMed ID: 19442324
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dual renin-angiotensin system blockade in heart failure.
    McMurray JJ; Granger CB; Ostergren J; Yusuf S; Pfeffer MA; Swedberg K
    J Am Coll Cardiol; 2009 Jul; 54(3):278; author reply 279-80. PubMed ID: 19589444
    [No Abstract]   [Full Text] [Related]  

  • 76. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
    Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
    Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Renin inhibition: a new modality for hypertension management.
    Siragy HM
    Curr Hypertens Rep; 2007 Aug; 9(4):291-4. PubMed ID: 17686379
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Plasma renin activity is a strong and independent prognostic indicator in patients with acute decompensated heart failure treated with renin-angiotensin system inhibitors.
    Ueda T; Kawakami R; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
    Circ J; 2015; 79(6):1307-14. PubMed ID: 25753468
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of the renin-angiotensin system and the prevention of stroke.
    Schrader J; Kulschewski A; Dendorfer A
    Am J Cardiovasc Drugs; 2007; 7(1):25-37. PubMed ID: 17355164
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Should all patients with significant proteinuria take a renin-angiotensin inhibitor?
    Thomas G; Nally JV
    Cleve Clin J Med; 2015 Nov; 82(11):716-8. PubMed ID: 26540320
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.